Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lycia Therapeutics
Biotech
Neumora overhauls C-suite after phase 3 flop—Chutes & Ladders
Neumora overhauls C-suite after phase 3 flop. Lycia lands veteran CMO. Navigator arrives at new CEO.
Darren Incorvaia
,
Zoey Becker
Feb 14, 2025 8:30am
Lilly-backed Lycia Therapeutics nabs $70M round
Sep 9, 2021 7:00am
Lilly doubles down on protein degradation with $35M Lycia deal
Aug 25, 2021 11:17am
BioTheryX skips the SPAC fervor in favor of eventual IPO
May 21, 2021 10:50am
Lycia uncloaks with $50M to tackle protein degradation
Jun 9, 2020 8:00am
